Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00185081 | Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging | PHASE1 | COMPLETED | 42 | — | — | Jul 1, 2005 | Dec 1, 2008 | Apr 7, 2016 | 1 | Netherlands |
| Name | Type | Description |
|---|---|---|
| Indium labeled IMP-205xm734 | DRUG | - |
Inclusion Criteria: * \> 18 years of age * Histologic or cytologic diagnosis of colorectal cancer * Karnofsky performance status \>70% Exclusion Criteria: * Pregnant or lactating women * Severe anorexia * Active second primary malignancy * Chemotherapy or radiotherapy within four weeks of study e...